Dynavax
-$0.15 (-1.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.
About DVAX
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
CEO
Ryan Spencer
Employees
245
Headquarters
Emeryville, California
Founded
1996
DVAX Key Statistics
Market Cap
1.07B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.30M
High Today
$9.47
Low Today
$9.20
Open Price
$9.46
Volume
1.28M
52 Week High
$11.84
52 Week Low
$3.58
DVAX Earnings
-$0.53
-$0.35
-$0.17
$0.01
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 4, After Hours